Research!America

Scientists at Memorial Sloan-Kettering Cancer Center , a Research!America member, have successfully treated a handful of leukemia patients with cutting-edge immune cell therapy. This therapy, similar to previous trials at the University of Pennsylvania and the National Cancer Institute, modifies the patient’€™s immune cells so that they recognize and kill the cancer cells. This experimental therapy provides a new avenue of treatment for patients who have undergone all of the traditional treatments like chemotherapy without achieving remission of the cancer. Read more about this exciting breakthrough in this New York Times article . The study’€™s senior author, Michael Sadelain, MD, PhD,...
Everyone understands that it’€™s necessary to take a hard look at the federal budget and cut costs. The problem with the sequestration is that it recklessly cuts every category of spending across the board at a time when we should maintain critical investments that will pay for themselves in the long run. One of my roles at the University of Pittsburgh is to advocate for federal investment in biomedical research through the National Institutes of Health (NIH), which administers grants to scientists around the country. About 80 percent of all funding for medical research in American universities comes from the NIH. One quarter of NIH funding is for research that leads directly and quickly to...
Research!America and its international partners, Research Australia, Research Canada and Research!Sweden, have signed a letter of agreement, capitalizing on a long-standing partnership among these research advocacy organizations. Over the past decade, Research!America, Research Australia and Research Canada have met informally on several occasions and presented and attended each organization’€™s annual meetings and conferences. Recently, Research!Sweden joined this alliance, bringing its unique programs, approaches and strategies to this international group. The agreement is intended to foster greater collaboration among the four organizations in an effort to leverage expertise,...
As sequestration threatens to obstruct progress in biomedical and health research, members of the research community are continuing to speak out against these across-the-board spending cuts. Research!America Board member Larry Shapiro, MD , dean of the Washington University School of Medicine in St. Louis’€™, shared his concerns in an article from the Associated Press. At Washington University in St. Louis and other research institutions across the country, ’€œautomatic cuts are causing anxiety among young researchers who are wondering what career options they’€™ll have if the current economic climate becomes ’€˜the new normal,’€™’€ according to the article. ’€This is all that’€™s being...
A new report from the Alzheimer’€™s Association reveals that one in three seniors suffer from some form of dementia or Alzheimer’€™s by their death. Deaths attributed to Alzheimer’€™s and dementia have increased 68% from 2000 to 2010. Harry Johns, president and CEO of the Alzheimer’€™s Association and Research!America Board member, said in an Alzheimer’€™s Association release that ’€œurgent, meaningful action is necessary, particularly as more and more people age into greater risk for developing a disease that today has no cure and no way to slow or stop its progression.’€ USA Today reports that the number of people with Alzheimer’€™s disease is expected to nearly triple by 2050, resulting...
Research!America extends our congratulations again to all of our 2013 Advocacy Award winners. The dinner was a wonderful opportunity to thank our supporters and advocates for all of their hard work and recognize leaders in the research and advocacy communities. This year’€™s Advocacy Award winners were Sen. Richard Burr (R-NC); Sen. Bob Casey (D-PA); John F. Crowley, patient advocate and chairman and CEO of Amicus Therapeutics, Inc.; Mark Rosenberg, MD, president and CEO of The Task Force for Global Health; John Mendelsohn, MD, director of the Khalifa Institute for Personalized Cancer Therapy and former president at The University of Texas MD Anderson Cancer Center; Diane Rehm, host of ’€œ...
Now available online, Research!America’€™s Annual Report, ’€œReasons for Research,’€ recounts the progress made in research advocacy by Research!America and its members representing academia, industry, scientific societies, patient groups and foundations. In addition to highlighting the 2012 Advocacy Awardees and Garfield Economic Impact Awardees, the report details Research!America initiatives such as the ongoing Save Research campaign and the Your Candidates’€“Your Health national voter education initiative. The annual report also includes polling data, statements from speakers at the National Health Research Forum ’€” including the heads of the federal health agencies ’€” and other...
Dear Research Advocate, Today, the Senate is planning to vote on a bipartisan continuing resolution from Sens. Mikulski and Shelby to fund the federal government through the end of the year. The good news is that the bill includes an increase, albeit small ($71 million) in NIH funding; Senator Harkin tried, unsuccessfully, unfortunately, to increase NIH even further, and Senator Durbin worked on an ambitious amendment to add more than $1.5 billion to the NIH budget. We truly appreciate the efforts of all of these champions and the fact that NIH funding was singled out for an increase on a bipartisan basis by the Appropriations Committee. The bad news is that sequestration will wipe out all...
Research!America will honor extraordinary leaders in biomedical and health research advocacy at the 17th Annual Advocacy Awards tonight, March 13, at the Andrew W. Mellon Auditorium in Washington, DC. This year’€™s Advocacy Award Winners are: Sens. Richard Burr (R-NC) and Bob Casey (D-PA); Diane Rehm, author and host of WAMU 88.5 and NPR’€™s ’€œThe Diane Rehm Show’€; John F. Crowley, patient advocate, inspirational entrepreneur, and chairman and CEO of Amicus Therapeutics, Inc.; John Mendelsohn, MD, director, Khalifa Institute for Personalized Cancer Therapy and former president of The University of Texas MD Anderson Cancer Center; Mark Rosenberg, MD, president and CEO, The Task Force for...
The National Multiple Sclerosis Society is marking this year’€™s multiple sclerosis Awareness Week with a national campaign, ’€œ Every Connection Counts .’€ The campaign seeks to raise awareness of MS and draw attention to the impact of MS; this disease ’€œdivides minds from bodies, pulls people from their lives and away from one another,’€ according to the National MS Society . Multiple sclerosis is a chronic, debilitating condition that is triggered by the body’€™s immune system attacking the central nervous system, which includes the brain, spine and optic nerves. This aberrant immune response targets myelin, a protective sheath that covers nerve fibers like rubber around an electrical...

Pages

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America